Rafaela Mesquita Bastos Cavalcante
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rafaela Mesquita Bastos Cavalcante has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Victor Alves Carneiro
Laboratory of Biofilms and Antimicrobial Agents (LaBAM/NUBEM), INTA University Center – UNINTA, Sobral, Brazil
7 shared publications - Jesús Alberto Pérez Guerrero
Laboratory of Biofilms and Antimicrobial Agents (LaBAM), Faculty of Medicine, Federal University of Ceara—UFC, Sobral, Brazil
4 shared publications - Maria Nágila Carneiro Matos
Laboratory of Biofilms and Antimicrobial Agents (LaBAM), Faculty of Medicine, Federal University of Ceara—UFC, Sobral, Brazil
4 shared publications - Antônio Mateus Gomes Pereira
Graduate Program in Biotechnology, Northeast Network of Biotechnology (RENORBIO), State University of Ceará, Campus Itaperi, Fortaleza 60714-903, Brazil
3 shared publications - Francisco Eduardo Aragão Catunda Júnior
Centro de Ciências Exatas, Naturais E Tecnológicas, Universidade Estadual da Região Tocantina Do Maranhão, Imperatriz, Brazil
3 shared publications - Geovany Amorim Gomes
Centro de Ciências Exatas e Tecnologicas, Universidade Estadual Vale do Acaraú, Sobral, Brazil
3 shared publications
Latest Publications
- Open Access
- 1 August 2025
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 17 (8) , e9218
Cannabidiol as a Green Adjuvant for Mupirocin-Based Formulations Against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus
Infections caused by Staphylococcus aureus, particularly methicillin-resistant strains (MRSA), continue to represent a major therapeutic challenge in clinical practice due to their high prevalence and limited treatment options. This study aimed to develop and evaluate an innovative in vitro topical formulation combining cannabidiol (CBD) and mupirocin, exploring its potential synergistic effects against both MRSA and methicillin-sensitive strains (MSSA). A series of assays were conducted, including physicochemical characterization, antibacterial activity tests, minimum inhibitory and bactericidal concentration determinations (MIC/MBC), checkerboard assays, time-kill curves, and biofilm inhibition analyses using crystal violet (CV) and MTT methodologies. The combined formulation demonstrated enhanced antimicrobial efficacy, with synergistic effects confirmed by fractional inhibitory concentration index (FICI ≤ 0.5) and time-kill assays showing ≥ 4 log10 CFU/mL reduction. Moreover, significant decreases in biofilm biomass and metabolic viability were observed. These findings suggest that the CBD–mupirocin formulation holds considerable promise for clinical application in the management of skin infections caused by resistant S. aureus strains.
- 1 August 2025
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 17 (8) , e9218
Open AccessCannabidiol as a Green Adjuvant for Mupirocin-Based Formulations Against Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus
Infections caused by Staphylococcus aureus, particularly methicillin-resistant strains (MRSA), continue to represent a major therapeutic challenge in clinical practice due to their high prevalence and limited treatment options. This study aimed to develop and evaluate an innovative in vitro topical formulation combining cannabidiol (CBD) and mupirocin, exploring its potential synergistic effects against both MRSA and methicillin-sensitive strains (MSSA). A series of assays were conducted, including physicochemical characterization, antibacterial activity tests, minimum inhibitory and bactericidal concentration determinations (MIC/MBC), checkerboard assays, time-kill curves, and biofilm inhibition analyses using crystal violet (CV) and MTT methodologies. The combined formulation demonstrated enhanced antimicrobial efficacy, with synergistic effects confirmed by fractional inhibitory concentration index (FICI ≤ 0.5) and time-kill assays showing ≥ 4 log10 CFU/mL reduction. Moreover, significant decreases in biofilm biomass and metabolic viability were observed. These findings suggest that the CBD–mupirocin formulation holds considerable promise for clinical application in the management of skin infections caused by resistant S. aureus strains.
- 13 July 2023
- Published by Springer Nature in Amino Acids
- Vol. 55 (8) , 1003-1012
K-aurein: A notable aurein 1.2-derived peptide that modulates Candida albicans filamentation and reduces biofilm biomass
Candida albicans is considered one of the most important opportunistic fungi due to the large arsenal of virulence factors that help throughout the progress of the infection. In this sense, antimicrobial peptides (AMPs) appear as an alternative, with great antifungal action. Among these, aurein 1.2 has been widely explored, becoming the basis for the discovery of new AMPs, such as K-aurein (K-au). Thus, this study evaluated the anti-C. albicans potential of K-au against virulence factors, planktonic growth, and biofilm formation of clinical isolates. Firstly, K-au antifungal activity was determined by the microdilution method and time-kill curve. The inhibition of hydrolytic enzyme secretion (proteinase, phospholipase, and hemolysin) and germ tube formation was tested. Then, the antibiofilm potential of K-au was verified through biomass quantification and scanning electron microscopy (SEM). All tests were compared with the classical antifungal drug, amphotericin B (AmB). The outcomes showed fungicidal action of K-au at 62.50 µg mL−1 for all isolates, with a time of action around 150–180 min, determined by the time-kill curve. K-au-treated cells decreased by around 40% of the germinative tube compared to the control. Additionally, K-au inhibited the biofilm formation by more than 90% compared to AmB and the control group. SEM images show apparent cellular disaggregation without the formation of filamentous structures. Therefore, the findings suggest a promising anti-C. albicans effect of K-au due to its fungicidal activity against planktonic cells, or its ability to inhibit important virulence factors like germ tube and biofilm formation. Thus, this peptide could be explored as a useful compound against C. albicans-related infection.
- 13 July 2023
- Published by Springer Nature in Amino Acids
- Vol. 55 (8) , 1003-1012
K-aurein: A notable aurein 1.2-derived peptide that modulates Candida albicans filamentation and reduces biofilm biomass
Candida albicans is considered one of the most important opportunistic fungi due to the large arsenal of virulence factors that help throughout the progress of the infection. In this sense, antimicrobial peptides (AMPs) appear as an alternative, with great antifungal action. Among these, aurein 1.2 has been widely explored, becoming the basis for the discovery of new AMPs, such as K-aurein (K-au). Thus, this study evaluated the anti-C. albicans potential of K-au against virulence factors, planktonic growth, and biofilm formation of clinical isolates. Firstly, K-au antifungal activity was determined by the microdilution method and time-kill curve. The inhibition of hydrolytic enzyme secretion (proteinase, phospholipase, and hemolysin) and germ tube formation was tested. Then, the antibiofilm potential of K-au was verified through biomass quantification and scanning electron microscopy (SEM). All tests were compared with the classical antifungal drug, amphotericin B (AmB). The outcomes showed fungicidal action of K-au at 62.50 µg mL−1 for all isolates, with a time of action around 150–180 min, determined by the time-kill curve. K-au-treated cells decreased by around 40% of the germinative tube compared to the control. Additionally, K-au inhibited the biofilm formation by more than 90% compared to AmB and the control group. SEM images show apparent cellular disaggregation without the formation of filamentous structures. Therefore, the findings suggest a promising anti-C. albicans effect of K-au due to its fungicidal activity against planktonic cells, or its ability to inhibit important virulence factors like germ tube and biofilm formation. Thus, this peptide could be explored as a useful compound against C. albicans-related infection.
- Open Access
- 22 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 11 (1) , 4
Anti-Staphylococcal Activity of Cinnamomum zeylanicum Essential Oil against Planktonic and Biofilm Cells Isolated from Canine Otological Infections
The aim of this study was to evaluate the phytochemical profile of Cinnamomum zeylanicum essential oil (CZEO) and their antimicrobial and antibiofilm activity against Staphylococcus strains isolated from canine otitis. First, the CZEO chemical composition was determined by gas chromatography-mass spectrometry (CG-MS). External otitis samples collected from dogs were submitted to staphylococcal isolation, followed by MALDI-TOF mass spectrometry identification. The antimicrobial action was tested against the isolates using the disk-diffusion and microdilution methods. The antibiofilm activity was evaluated by CZEO-based concentrations, subMIC for biofilm formation and supraMIC against preformed biofilm, quantified by crystal violet (CV) staining and CFU counting. The chemical analysis revealed that (E)-cinnamaldehyde, eugenol and (E)-cinnamyl acetate were the main compounds in the CZEO, representing 77.42, 8.17 and 4.50%, respectively. Two strains of three different species, S. saprophyticus, S. schleiferi and S. pseudintermedius, were identified. The disk-diffusion test showed an inhibitory zone diameter, ranging from 34.0 to 49.5 mm, while the MIC and MBC values were around 500 and 1000 µg/mL. SubMIC demonstrated an inhibition on biofilm formation against 4 out the 6 strains tested. On mature biofilm, the CZEO-based supraMIC groups had slightly change on biomass, however, the biofilm cell viability decreased the CFU in 3 magnitude orders.
- 22 December 2021
- Published by MDPI AG in Antibiotics
- Vol. 11 (1) , 4
Open AccessAnti-Staphylococcal Activity of Cinnamomum zeylanicum Essential Oil against Planktonic and Biofilm Cells Isolated from Canine Otological Infections
The aim of this study was to evaluate the phytochemical profile of Cinnamomum zeylanicum essential oil (CZEO) and their antimicrobial and antibiofilm activity against Staphylococcus strains isolated from canine otitis. First, the CZEO chemical composition was determined by gas chromatography-mass spectrometry (CG-MS). External otitis samples collected from dogs were submitted to staphylococcal isolation, followed by MALDI-TOF mass spectrometry identification. The antimicrobial action was tested against the isolates using the disk-diffusion and microdilution methods. The antibiofilm activity was evaluated by CZEO-based concentrations, subMIC for biofilm formation and supraMIC against preformed biofilm, quantified by crystal violet (CV) staining and CFU counting. The chemical analysis revealed that (E)-cinnamaldehyde, eugenol and (E)-cinnamyl acetate were the main compounds in the CZEO, representing 77.42, 8.17 and 4.50%, respectively. Two strains of three different species, S. saprophyticus, S. schleiferi and S. pseudintermedius, were identified. The disk-diffusion test showed an inhibitory zone diameter, ranging from 34.0 to 49.5 mm, while the MIC and MBC values were around 500 and 1000 µg/mL. SubMIC demonstrated an inhibition on biofilm formation against 4 out the 6 strains tested. On mature biofilm, the CZEO-based supraMIC groups had slightly change on biomass, however, the biofilm cell viability decreased the CFU in 3 magnitude orders.
- Open Access
- 7 October 2020
- Published by IntechOpen
Essential Oils as an Innovative Approach against Biofilm of Multidrug-ResistantStaphylococcus aureus
Staphylococcus aureus is one of the most common pathogens that cause recurrent, chronic, and biofilm-related diseases. Biofilms are the major form of bacterial structures capable of secreting polysaccharides that provide intrinsic protection against environmental stress like high concentrations of antibiotics. This, along with the emergence of multidrug-resistant strains, has made S. aureus infections a worldwide problem as a result of the inefficiency of the conventional medications. Plant essential oils (EOs) are an important source for drug discovery and pharmaceutical development due to their diverse biological activities, such as antimicrobial agents. The EOs’ microbicide action is extensively reported at the scientific literature and frequently associated with bioactive molecules, such as aldehydes and terpenes. However, the ability of some EOs to inhibit biofilm formation has been poorly explored and it is still unclear how they could be applied in specific treatments against well-known infections. Therefore, this chapter will address virulence factors and biofilm formation of S. aureus, as well as bioprospecting of essential oil as a promising source in the search for new bioactive compounds employed in the fight against this microorganism.
- 7 October 2020
- Published by IntechOpen
Open AccessEssential Oils as an Innovative Approach against Biofilm of Multidrug-ResistantStaphylococcus aureus
Staphylococcus aureus is one of the most common pathogens that cause recurrent, chronic, and biofilm-related diseases. Biofilms are the major form of bacterial structures capable of secreting polysaccharides that provide intrinsic protection against environmental stress like high concentrations of antibiotics. This, along with the emergence of multidrug-resistant strains, has made S. aureus infections a worldwide problem as a result of the inefficiency of the conventional medications. Plant essential oils (EOs) are an important source for drug discovery and pharmaceutical development due to their diverse biological activities, such as antimicrobial agents. The EOs’ microbicide action is extensively reported at the scientific literature and frequently associated with bioactive molecules, such as aldehydes and terpenes. However, the ability of some EOs to inhibit biofilm formation has been poorly explored and it is still unclear how they could be applied in specific treatments against well-known infections. Therefore, this chapter will address virulence factors and biofilm formation of S. aureus, as well as bioprospecting of essential oil as a promising source in the search for new bioactive compounds employed in the fight against this microorganism.
- Open Access
Chemical Composition and Antimicrobial Effectiveness of Ocimum gratissimum L. Essential Oil Against Multidrug-Resistant Isolates of Staphylococcus aureus and Escherichia coli
The study investigated the antimicrobial activity of the essential oil extract of Ocimum gratissimum L. (EOOG) against multiresistant microorganisms in planktonic and biofilm form. Hydrodistillation was used to obtain the EOOG, and the analysis of chemical composition was done by gas chromatography coupled with mass spectrometry (GC/MS) and flame ionization detection (GC/FID). EOOG biological activity was verified against isolates of Staphylococcus aureus and Escherichia coli, using four strains for each species. The antibacterial action of EOOG was determined by disk diffusion, microdilution (MIC/MBC), growth curve under sub-MIC exposure, and the combinatorial activity with ciprofloxacin (CIP) and oxacillin (OXA) were determined by checkerboard assay. The EOOG antibiofilm action was performed against the established biofilm and analyzed by crystal violet, colony-forming unit count, and SEM analyses. EOOG yielded 1.66% w/w, with eugenol as the major component (74.83%). The MIC was 1000 µg/mL for the most tested strains. The growth curve showed a lag phase delay for both species, mainly S. aureus, and reduced the growth level of E. coli by half. The combination of EOOG with OXA and CIP led to an additive action for S. aureus. A significant reduction in biofilm biomass and cell viability was verified for S. aureus and E. coli. In conclusion, EOOG has relevant potential as a natural alternative to treat infections caused by multiresistant strains.
Open AccessChemical Composition and Antimicrobial Effectiveness of Ocimum gratissimum L. Essential Oil Against Multidrug-Resistant Isolates of Staphylococcus aureus and Escherichia coli
The study investigated the antimicrobial activity of the essential oil extract of Ocimum gratissimum L. (EOOG) against multiresistant microorganisms in planktonic and biofilm form. Hydrodistillation was used to obtain the EOOG, and the analysis of chemical composition was done by gas chromatography coupled with mass spectrometry (GC/MS) and flame ionization detection (GC/FID). EOOG biological activity was verified against isolates of Staphylococcus aureus and Escherichia coli, using four strains for each species. The antibacterial action of EOOG was determined by disk diffusion, microdilution (MIC/MBC), growth curve under sub-MIC exposure, and the combinatorial activity with ciprofloxacin (CIP) and oxacillin (OXA) were determined by checkerboard assay. The EOOG antibiofilm action was performed against the established biofilm and analyzed by crystal violet, colony-forming unit count, and SEM analyses. EOOG yielded 1.66% w/w, with eugenol as the major component (74.83%). The MIC was 1000 µg/mL for the most tested strains. The growth curve showed a lag phase delay for both species, mainly S. aureus, and reduced the growth level of E. coli by half. The combination of EOOG with OXA and CIP led to an additive action for S. aureus. A significant reduction in biofilm biomass and cell viability was verified for S. aureus and E. coli. In conclusion, EOOG has relevant potential as a natural alternative to treat infections caused by multiresistant strains.
- Open Access
Effect of Leguminous Lectins on the Growth of Rhizobium tropici CIAT899
Rhizobium tropici is a Gram-negative bacterium that induces nodules and fixed atmospheric nitrogen in symbiotic association with Phaseolus vulgaris (common bean) and some other leguminous species. Lectins are proteins that specifically bind to carbohydrates and, consequently, modulate different biological functions. In this study, the d-glucose/ d-mannose-binding lectins (from seeds of Dioclea megacarpa, D. rostrata and D. violacea) and D-galactose-binding lectins (from seeds of Bauhinia variegata, Erythina velutina and Vatairea macrocarpa) were purified using chromatographic techniques and evaluated for their effect on the growth of R. tropici CIAT899. All lectins were assayed with a satisfactory degree of purity according to SDS-PAGE analysis, and stimulated bacterial growth; in particular, the Dioclea rostrata lectin was the most active among all tested proteins. As confirmed in the present study, both d-galactose- and d-glucose/d-mannose-binding lectins purified from the seeds of leguminous plants may be powerful biotechnological tools to stimulate the growth of R. tropici CIAT99, thus improving symbiotic interaction between rhizobia and common bean and, hence, the production of this field crop.
Open AccessEffect of Leguminous Lectins on the Growth of Rhizobium tropici CIAT899
Rhizobium tropici is a Gram-negative bacterium that induces nodules and fixed atmospheric nitrogen in symbiotic association with Phaseolus vulgaris (common bean) and some other leguminous species. Lectins are proteins that specifically bind to carbohydrates and, consequently, modulate different biological functions. In this study, the d-glucose/ d-mannose-binding lectins (from seeds of Dioclea megacarpa, D. rostrata and D. violacea) and D-galactose-binding lectins (from seeds of Bauhinia variegata, Erythina velutina and Vatairea macrocarpa) were purified using chromatographic techniques and evaluated for their effect on the growth of R. tropici CIAT899. All lectins were assayed with a satisfactory degree of purity according to SDS-PAGE analysis, and stimulated bacterial growth; in particular, the Dioclea rostrata lectin was the most active among all tested proteins. As confirmed in the present study, both d-galactose- and d-glucose/d-mannose-binding lectins purified from the seeds of leguminous plants may be powerful biotechnological tools to stimulate the growth of R. tropici CIAT99, thus improving symbiotic interaction between rhizobia and common bean and, hence, the production of this field crop.
- Open Access
Effect of the Lectin of Bauhinia variegata and Its Recombinant Isoform on Surgically Induced Skin Wounds in a Murine Model
Lectins are a structurally heterogeneous group of highly specific carbohydrate-binding proteins. Due to their great biotechnological potential, lectins are widely used in biomedical research. The purpose of the present study was to evaluate the healing potential of the lectin of Bauhinia variegata (nBVL) and its recombinant isoform (rBVL-1). Following surgical creation of dorsal skin wounds, seven groups of mice were submitted to topical treatment for 12 days with lectin, D-galactose, BSA and saline. The animals were anesthetized and euthanized on POD 2, 7 and 12 in order to evaluate the healing potential of each treatment. The parameters considered included wound size, contraction rate, epithelialization rate and histopathological findings. Wound closure was fastest in animals treated with rBVL-1 (POD 7). nBVL was more effective than the controls. All skin layers were reconstructed and keratin deposition increased. Our findings indicate that the lectin of Bauhinia variegata possesses pro-healing properties and may be employed in the treatment of acute skin wounds.
Open AccessEffect of the Lectin of Bauhinia variegata and Its Recombinant Isoform on Surgically Induced Skin Wounds in a Murine Model
Lectins are a structurally heterogeneous group of highly specific carbohydrate-binding proteins. Due to their great biotechnological potential, lectins are widely used in biomedical research. The purpose of the present study was to evaluate the healing potential of the lectin of Bauhinia variegata (nBVL) and its recombinant isoform (rBVL-1). Following surgical creation of dorsal skin wounds, seven groups of mice were submitted to topical treatment for 12 days with lectin, D-galactose, BSA and saline. The animals were anesthetized and euthanized on POD 2, 7 and 12 in order to evaluate the healing potential of each treatment. The parameters considered included wound size, contraction rate, epithelialization rate and histopathological findings. Wound closure was fastest in animals treated with rBVL-1 (POD 7). nBVL was more effective than the controls. All skin layers were reconstructed and keratin deposition increased. Our findings indicate that the lectin of Bauhinia variegata possesses pro-healing properties and may be employed in the treatment of acute skin wounds.